Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer
Aiswarya Chaudhuri, Dulla Naveen Kumar, Dinesh Kumar, Ashish Kumar Agrawal
Topics & Concepts
DocetaxelErlotinibTriple-negative breast cancerSolid lipid nanoparticlePharmacologyBreast cancerCancerMedicineChemistryCancer researchInternal medicineDrugEpidermal growth factor receptorNanoparticle-Based Drug DeliveryComputational Drug Discovery MethodsCurcumin's Biomedical Applications